Evoke plc (LON:EVOK – Get Free Report) fell 10% on Thursday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares changed hands during mid-day trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
A number of equities analysts have recently commented on the stock. Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th. Berenberg Bank dropped their price objective on shares of Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th.
Read Our Latest Stock Analysis on Evoke
Evoke Trading Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. Research analysts expect that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.
Insider Transactions at Evoke
In other Evoke news, insider Andrea Gisle Joosen acquired 14,572 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was purchased at an average price of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
About Evoke
Featured Articles
- Five stocks we like better than Evoke
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- MarketBeat Week in Review – 03/24 – 03/28
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Should You Invest in Penny Stocks?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.